Ira Mellman

24PUBLICATIONS
150CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Feb 19, 2025
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer.

Zachary Sethna, Pablo Guasp, Charlotte Reiche

|Jan 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.

Matthew D Galsky, Mark Kockx, Juliette Roels

|Jan 17, 2025
Publisher Correction: TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation.

Katherine Nutsch, Karl L Banta, Thomas D Wu

|Dec 16, 2024
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation.

Katherine Nutsch, Karl L Banta, Thomas D Wu

|Aug 20, 2024
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.

Xiangnan Guan, Ruozhen Hu, Yoonha Choi

|May 30, 2024
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.

Xiangnan Guan, Ruozhen Hu, Yoonha Choi

Pageof 4

Frequent Collaborators

6 joint publications

Robert J Johnston

6 joint publications

Barzin Y Nabet

4 joint publications

Katherine Williams

4 joint publications

David S Shames